Bata India Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 20, 2025, 5:01 pm

Competitors of Bata India Ltd

All Competitor Stocks of Bata India Ltd

Quarterly Result

Last Updated: August 20, 2025, 1:00 pm

Below is a detailed analysis of the quarterly data for Bata India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 942.00 Cr.. The value appears strong and on an upward trend. It has increased from 788.00 Cr. (Mar 2025) to 942.00 Cr., marking an increase of 154.00 Cr..
• For Expenses, as of Jun 2025, the value is 743.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 610.00 Cr. (Mar 2025) to 743.00 Cr., marking an increase of 133.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 199.00 Cr.. The value appears strong and on an upward trend. It has increased from 178.00 Cr. (Mar 2025) to 199.00 Cr., marking an increase of 21.00 Cr..
• For OPM %, as of Jun 2025, the value is 21.00%. The value appears to be declining and may need further review. It has decreased from 23.00% (Mar 2025) to 21.00%, marking a decrease of 2.00%.
• For Other Income, as of Jun 2025, the value is 12.00 Cr.. The value appears to be declining and may need further review. It has decreased from 23.00 Cr. (Mar 2025) to 12.00 Cr., marking a decrease of 11.00 Cr..
• For Interest, as of Jun 2025, the value is 35.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 35.00 Cr..
• For Depreciation, as of Jun 2025, the value is 106.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 104.00 Cr. (Mar 2025) to 106.00 Cr., marking an increase of 2.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 70.00 Cr.. The value appears strong and on an upward trend. It has increased from 62.00 Cr. (Mar 2025) to 70.00 Cr., marking an increase of 8.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 26.00%.
• For Net Profit, as of Jun 2025, the value is 52.00 Cr.. The value appears strong and on an upward trend. It has increased from 46.00 Cr. (Mar 2025) to 52.00 Cr., marking an increase of 6.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 4.05. The value appears strong and on an upward trend. It has increased from 3.57 (Mar 2025) to 4.05, marking an increase of 0.48.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 22, 2025, 5:28 pm

Growth

Last Updated: September 5, 2025, 12:40 am

Balance Sheet

Last Updated: July 25, 2025, 3:31 pm

Below is a detailed analysis of the balance sheet data for Bata India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 64.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 64.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,511.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,463.00 Cr. (Mar 2024) to 1,511.00 Cr., marking an increase of 48.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1,446.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1,357.00 Cr. (Mar 2024) to 1,446.00 Cr., marking an increase of 89.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 801.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 466.00 Cr. (Mar 2024) to 801.00 Cr., marking an increase of 335.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 3,823.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,350.00 Cr. (Mar 2024) to 3,823.00 Cr., marking an increase of 473.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,800.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,509.00 Cr. (Mar 2024) to 1,800.00 Cr., marking an increase of 291.00 Cr..
• For CWIP, as of Mar 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2024) to 14.00 Cr., marking an increase of 10.00 Cr..
• For Investments, as of Mar 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 1.00 Cr., marking an increase of 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 2,008.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,837.00 Cr. (Mar 2024) to 2,008.00 Cr., marking an increase of 171.00 Cr..
• For Total Assets, as of Mar 2025, the value is 3,823.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,350.00 Cr. (Mar 2024) to 3,823.00 Cr., marking an increase of 473.00 Cr..

Notably, the Reserves (1,511.00 Cr.) exceed the Borrowings (1,446.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Bata India Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 25.73. This value is within the healthy range. It has increased from 20.42 (Mar 24) to 25.73, marking an increase of 5.31.
• For Diluted EPS (Rs.), as of Mar 25, the value is 25.73. This value is within the healthy range. It has increased from 20.42 (Mar 24) to 25.73, marking an increase of 5.31.
• For Cash EPS (Rs.), as of Mar 25, the value is 54.62. This value is within the healthy range. It has increased from 46.81 (Mar 24) to 54.62, marking an increase of 7.81.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 122.54. It has increased from 118.80 (Mar 24) to 122.54, marking an increase of 3.74.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 122.54. It has increased from 118.80 (Mar 24) to 122.54, marking an increase of 3.74.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 271.44. It has increased from 270.65 (Mar 24) to 271.44, marking an increase of 0.79.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 62.48. This value is within the healthy range. It has decreased from 65.95 (Mar 24) to 62.48, marking a decrease of 3.47.
• For PBIT / Share (Rs.), as of Mar 25, the value is 33.59. This value is within the healthy range. It has decreased from 39.57 (Mar 24) to 33.59, marking a decrease of 5.98.
• For PBT / Share (Rs.), as of Mar 25, the value is 33.17. This value is within the healthy range. It has increased from 27.28 (Mar 24) to 33.17, marking an increase of 5.89.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 25.73. This value is within the healthy range. It has increased from 20.42 (Mar 24) to 25.73, marking an increase of 5.31.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 25.73. This value is within the healthy range. It has increased from 20.42 (Mar 24) to 25.73, marking an increase of 5.31.
• For PBDIT Margin (%), as of Mar 25, the value is 23.01. This value is within the healthy range. It has decreased from 24.36 (Mar 24) to 23.01, marking a decrease of 1.35.
• For PBIT Margin (%), as of Mar 25, the value is 12.37. This value is within the healthy range. It has decreased from 14.61 (Mar 24) to 12.37, marking a decrease of 2.24.
• For PBT Margin (%), as of Mar 25, the value is 12.22. This value is within the healthy range. It has increased from 10.07 (Mar 24) to 12.22, marking an increase of 2.15.
• For Net Profit Margin (%), as of Mar 25, the value is 9.47. This value is within the healthy range. It has increased from 7.54 (Mar 24) to 9.47, marking an increase of 1.93.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 9.47. This value is within the healthy range. It has increased from 7.54 (Mar 24) to 9.47, marking an increase of 1.93.
• For Return on Networth / Equity (%), as of Mar 25, the value is 20.99. This value is within the healthy range. It has increased from 17.19 (Mar 24) to 20.99, marking an increase of 3.80.
• For Return on Capital Employeed (%), as of Mar 25, the value is 14.96. This value is within the healthy range. It has decreased from 19.45 (Mar 24) to 14.96, marking a decrease of 4.49.
• For Return On Assets (%), as of Mar 25, the value is 8.64. This value is within the healthy range. It has increased from 7.83 (Mar 24) to 8.64, marking an increase of 0.81.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.97. It has decreased from 1.05 (Mar 24) to 0.97, marking a decrease of 0.08.
• For Current Ratio (X), as of Mar 25, the value is 1.84. This value is within the healthy range. It has decreased from 2.11 (Mar 24) to 1.84, marking a decrease of 0.27.
• For Quick Ratio (X), as of Mar 25, the value is 0.96. This value is below the healthy minimum of 1. It has increased from 0.84 (Mar 24) to 0.96, marking an increase of 0.12.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.00. This value is within the healthy range. It has increased from 0.26 (Mar 24) to 4.00, marking an increase of 3.74.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 85.51. This value exceeds the healthy maximum of 50. It has increased from 66.09 (Mar 24) to 85.51, marking an increase of 19.42.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 40.28. This value is within the healthy range. It has increased from 28.84 (Mar 24) to 40.28, marking an increase of 11.44.
• For Earning Retention Ratio (%), as of Mar 25, the value is 14.49. This value is below the healthy minimum of 40. It has decreased from 33.91 (Mar 24) to 14.49, marking a decrease of 19.42.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 59.72. This value is within the healthy range. It has decreased from 71.16 (Mar 24) to 59.72, marking a decrease of 11.44.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 6.25. This value is within the healthy range. It has decreased from 7.24 (Mar 24) to 6.25, marking a decrease of 0.99.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.62. This value is below the healthy minimum of 3. It has decreased from 3.59 (Mar 24) to 2.62, marking a decrease of 0.97.
• For Enterprise Value (Cr.), as of Mar 25, the value is 15,038.26. It has decreased from 17,126.47 (Mar 24) to 15,038.26, marking a decrease of 2,088.21.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.31. This value exceeds the healthy maximum of 3. It has decreased from 4.92 (Mar 24) to 4.31, marking a decrease of 0.61.
• For EV / EBITDA (X), as of Mar 25, the value is 18.73. This value exceeds the healthy maximum of 15. It has decreased from 20.21 (Mar 24) to 18.73, marking a decrease of 1.48.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.49. This value exceeds the healthy maximum of 3. It has decreased from 5.04 (Mar 24) to 4.49, marking a decrease of 0.55.
• For Retention Ratios (%), as of Mar 25, the value is 14.48. This value is below the healthy minimum of 30. It has decreased from 33.90 (Mar 24) to 14.48, marking a decrease of 19.42.
• For Price / BV (X), as of Mar 25, the value is 9.95. This value exceeds the healthy maximum of 3. It has decreased from 11.48 (Mar 24) to 9.95, marking a decrease of 1.53.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.49. This value exceeds the healthy maximum of 3. It has decreased from 5.04 (Mar 24) to 4.49, marking a decrease of 0.55.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness